← Evidence map

ArticleJournal of comparative effectiveness research2024

First in class, best in class or a wild card: who will dominate the anti-obesity medication market?

Emma Collins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38808628